Answers are grounded in this paper and cite their sources.
Acute promyelocytic leukemia is frequently accompanied by coagulation abnormalities usually described as laboratorial disseminated intravascular coagulation, which is the main cause of morbidity and early mortality. Aberrant activation of the coagulation cascade and hyperfibrinolysis play an important role in the pathogenesis of bleeding diathesis, but their contribution varies from case to case. Here we review the main laboratorial findings and the recommended clinical management of coagulopathy associated with acute promyelocytic leukemia.
No takes yet. Share an insight, caveat, or question.
Jácomo et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: